Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of GSK 2189242A Pneumococcal Vaccine in Gambian Infants and Children
NCT01262872Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2011
- Primary completion
- Mar 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GSK 2189242A in pneumococcal infection, sponsored by GSK. Started Feb 2011; status: completed.
02
Drugs
GSK 2189242A
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01262872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01262872.